Understanding patient barriers to adherence is a key starting point for improving outcomes—particularly for diabetics. Those barriers come in many flavors: access, habit, health literacy, behavioral health issues, even cultural variances in how a patient views health practices and the US health system as a whole. It’s a nagging problem, as is evidenced by the continued relevance of this decade-old list of barriers and strategies for overcoming them. Hosted by Pharmacy Times magazine, a panel of care providers studying collaborative care in diabetes management recently came up with this practical suggestion: explain exactly what is in an injectable, how it works, and why it is important. Then, do the first injection with a patient in the office or pharmacy.
It’s safe to say that we are all in agreement: this flu season has been wretched. The supply chain for certain drugs, saline solution, and other supplies has been tight across the country following a trifecta of nasty hurricanes. Since early November, the FDA has been actively updating healthcare providers with guidance for managing the acute shortage of such products, including some specific to pharmacies.